New Guideline Details Diagnosis, Treatment of Acute Pulmonary Embolism

Follow Drugslib on

By Lori Solomon HealthDay Reporter

Medically reviewed by Drugs.com

via HealthDay

MONDAY, Feb. 23, 2026 -- A new clinical classification system is presented to define the severity of an acute pulmonary embolism (PE) and assist in developing adult treatment strategies in a clinical practice guideline issued by the American Heart Association and the American College of Cardiology and published online Feb. 19 in both Circulation and the Journal of the American College of Cardiology.

Mark A. Creager, M.D., from the Dartmouth Hitchcock Medical Center in Lebanon, New Hampshire, and colleagues from the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines developed this evidence-based and patient-centered guideline after a comprehensive literature search.

The guideline encompasses the period from the onset of symptoms through clinical follow-up, focusing on risk outcomes assessment, clinical diagnosis, appropriate adjunctive cardiovascular testing, and management of both acute and early postacute PE. The guideline explains risk factors for acute PE (e.g., recent surgery or hospitalization, trauma, prolonged immobility, pregnancy, obesity, cancer, and blood clotting disorders) and provides diagnostic strategies and treatment options to improve outcomes for patients with acute PE across levels of resources and care settings (e.g., emergency department, inpatient setting, or outpatient clinic). The guideline also provides recommendations for follow-up care after acute PE, including safe physical activity, travel considerations, and long-term use of anticoagulant medications.

"We anticipate that decisions guided by these recommendations will result in more rapid diagnosis and application of effective, evidence-based treatments, leading to better outcomes, such as decreased risk of death and disability, for people with acute pulmonary embolism," Creager said in a statement.

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2026-02-24 09:41

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords